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CHAPTER – I  
INTRODUCTION 
 
BACKGROUND OF THE STUDY 
 
Cancer is the second leading cause of death in our country. The term cancer is used to 
refer to malignant neoplasms. Cancer is a disease of the cell in which the normal mechanisms 
of the control of growth and proliferation have been altered. The experience of cancer is 
changing for our clients and families. The National Cancer Institute [NCI] estimates that 8.9 
millions Americans alive today have a history of  cancer. 
 
Treatment options offered to cancer patients should be based on realistic and 
achievable goals for each specific type of cancer.The possible treatment goals may include 
complete eradication of malignant diseases[cure], prolonged survival and containment of 
cancer cell growth[control],or relief of symptoms associated with  the disease 
[palliation].Multiple treatment modalities  including chemotherapy, radiation therapy, surgery,  
and biologic response modifier therapy may be used at various times. 
 
The goals of chemotherapy [cure, control, palliation] chemotherapeutic agents  may be 
administered in the hospital, clinic, or home settings by topical, oral, intravenous, intramuscular, 
subcutaneous, arterial, intracavitary, and intrathecal routes. The administration route depends 
on the type of agent, dose, and the type,location, and extent of tumour being treated. Special 
care must be taken whenever the chemotherapeutic agents are administered. 
Chemotherapeutic agents  have a range of side effects that depend on the type of medications 
used. Common side effects include; fatigue, headace, severe pain, allergic reactions, loss of 
appetite, nausea, vomiting, black pigmentation, sepsis etc. 
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According to the [International association for the study of pain]’’pain is an unpleasant 
sensory and emotional experience in association with actual or potential tissue damage.” 
Approximately  30% to 50% with cancer experience pain while undergoing the side effects of 
cancer treatment such as chemotherapy, radiation therapy, and tumor excerting pressure on 
nerve., pain arises from any number of situations. Injury is a major cause, but pain may also 
arise from illness. 
 
The word intravenous simply “ within  a vein”. Therapies administered intravenously 
are often called speciality pharmaceuticals.If the cannula is not inserted correctly, or the vein is 
particularly fragile and ruptures, blood may leak into the surrounding tissue, this situation is 
known as a “tissuing” or a “blowing vein” especially the chemotherapeutic agents It may  cause 
extravasation of the drug which can lead to edema, pain, and tissue damage, and even 
necrosis depending on the medications. 
 
According to Dr John Diamond [2009] Up to 80% of cancer patients are reported to 
have died from complications from, treatment and side effects or related symptoms. The 
injection site reactions are local skin reactions. Mainly [extravasation].One of the most 
important nurses responsibility to assess the pain and give supportive complimentary therapy. 
There are many ways to relieve pain. Treatments vary from individual to  individuals depending 
upon the type  and severity of pain. 
 
The ultimate responsibility of the nurse is to provide comfort and relieve distress. One 
of the method that can be used to relieve the pain is cryotherapy. The cryotherapy is applied to 
the skin the initial response is vasoconstriction of the blood vessels. The mechanism of 
destruction in cryotherapy is necrosis, which results from the freezing and thawing of cells. 
Treated areas reepithelialize. Adverse effects of cryotherapy are usually minor . The 
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mechanism of action in cryotherapy can be divided into 3 phases:  heat transfer, cell injury, and  
inflammation. 
Cryotherapy as been used to relieve the pain for many years. The mechanisms of 
action is the stimulation of cold receptors which send back impulses which have to pass into 
the spinal cord via the posterior routes. The cold stimulation itself could be considered noxious 
and as such cause  stimulation of areas in the mid brain which may in turn  release beta 
endorphins into the posterior horn ,with a consequent reduction of pain. This will reduce the 
pain temporarily. 
 
NEED FOR THE STUDY 
The world wide burden of cancer is a major health problem with 8 millions new cases 
and 5 millions death per year. The burden from cancer may be described in terms of incidence. 
According  to WHO The number of new cases per 100,000 each year. Prevalence is the 
number of people at a given point of time with a cancer diagnosis. Cancer incidence , 
prevalence, and mortality are higher in industrialized countries. WHO has proposed a global 
goal of reducing such chronic diseases death rate by 2% per annum form 2006to 2015. 
 
             Cancer prevalence in India is estimated to be around 2.5 million, with over 8,00,000 
new cases and 5,50,000 deaths occurring each year due to this disease. More than 70% of the 
cases report for diagnostic and treatment services in the advanced stages of the disease, 
which has lead to a poor survival and high mortality rate 
 
According to National cancer control programme[NCCP] estimated 7.6 millions 
mortalities were attributed to cancers in 2005 across the globe. The prevalence rate  for all 
reported cancers is at 25 millions projected to ascend to 30 millions around the year of 2020. 
 
Lisa schalmeister. [2008] reported a study to monitor the incidence, management, and 
relieving pain, after the intravenous administration of chemotherapeutic agents. Two clinical 
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trials  were performed.Extravasation  was the  most common problem  of this drugs. The 
incidence rate was 0.01% to 6%. 
According to WHO The incidence of chemotherapeutic extravasation injuries including 
pain ranges from 0.5% to 0.6%. People die from chemotherapy because it is extremely toxic 
and ineffective . Most people die from chemotherapy rather than the cancer itself.The mortality 
rate is the number of death  caused by   cancer in the specified population in a given year. 
American  cancer society [ACS] show changes in the mortality rates for cancer in both males 
and females. 
 
Espinosa E et al.,[1996] conducted a study to assess the toxicities of the cisplatin and 
leucoverin combination with  advanced non small cell carcinoma. Finally the study findings 
reveals that  this regimen cannot be recommend for the patients. Due to its low response rate. 
And it was highly toxic. 
 
During administration of chemotherapeutic agents The nurses responsibility is very 
important.The intravenous cannula is not inserted correctly it will cause severe pain, 
extravasation,and pigmentation.Injury  is a major cause of pain. Chemotherapeutic drugs itself 
it will cause pain. 
 
According to American nurses association [ANA] Pain is a feeling of distress, suffering 
of agony. Pain may also arises from an illness. One of most important nurses responsibility is 
to assess the pain and give supportive therapy. Cryotherapy is a complimentary therapy that 
has the potential for use by nurse in a  multidisciplinary pain management programme. Pain 
assessment is an important part  of any medical evaluation, and pain management is an  
important part of care. Left untreated, pain can suppress the immune system,  It will leads to 
depression. 
 
One of the best method that can be used to relieve the pain is cryotherapy. 
Cryotherapy involves the application of cold to relieve the symptoms. It numbs pain, reduces 
joint swelling, constricts blood vessels, and block nerve impulses to the affected area.cold can 
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be applied by using cold compresses, crushed ice, in a plastic bag wrapped in a towel, frozen 
gel packs. 
Sabitha.P. B et al [2008] reported a study to assess the effectiveness of  cryotherapy 
on arteriovenous fistula related pain in haemodialysis patients.On experimental group  were 
found to be very effective.[p=0.001] so cryotherapy is effective in reducing puncture pain in 
haemodialysis patients. 
 
Cryotherapy is the local or general use of low temperatures in medical therapy or the 
removal of heat from a body part.The term “crotherapy ‘’comes from a greek word cryo means 
“cold” Therapy means “cure” The ultimate goal of  cryotherapy is to decrease the cellular 
metabolism, increase the cellular survival,decrease the inflammation, decrease the pain and 
spasm and promote vasoconstriction.Cryotherapy is an application of ice pack applied over an 
injured area of the  body.The immediate effect of cryotherapy is to produce immediate 
vasconstriction and reflexive vasodilatation. 
                            
STATEMENT OF THE PROBLEM 
 
A study to assess the effectiveness of cryotherapy on pain after  the intravenous  
administration of chemotherapeutic agents among  patients with cancer in  selected hospital, 
Cherthala, Alappuzha.  
. 
OBJECTIVES 
 
1. To assess the effectiveness of cryotherapy on pain before and after the 
intravenous administration of chemotherapeutic agents among the cancer patients 
in experimental group. 
2. To compare the mean difference on pain  among the cancer patients between the 
experimental and control group.  
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3. To test the association between the mean difference on pain and selected factors 
among the cancer patients in experimental group. 
HYPOTHESIS 
 
H1 : There will be a significant difference in pain before and after cryotherapy  
among patients with cancer in experimental group. 
H2 : There will be a significant difference in the mean difference  of pain among 
cancer patients  between the  experimental and control group. 
H3 : There will be a significant association between  mean difference  in pain and 
selected factors among  patients with cancer in experimental group. 
 
OPERATIONAL DEFINITIONS 
 
1. Pain: Pain is “an unpleasant sensory and emotional experience associated with 
actual  or potential tissue damage, or described in terms of such  damage.” 
 
2. Cryotherapy: Cryotherapy is an application of ice pack applied over an injured area 
of the  body. It numbs pain,reduces joint swelling, constricts blood vessels, and block nerve 
impulses to the affected area.cold can be applied by using cold compresses, crushed ice, in a 
plastic bag wrapped in a towel, frozen gel packs. 
 
3. Cancer Patients: Cancer patients refers to those patients who were diagnosed to 
have malignancy by the oncologists. 
 
4. Chemotherapy: Chemotherapy is the systemic treatment of cancer with chemicals .  
In chemotherapy, antineoplastic agents are used in an attempt to destroy tumour cells by 
interfering with cellular functions and reproduction. 
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5. Selected Factors: Refers to those  factors  that can influence the pain reduction 
after the intravenous administration of chemotheropeutic agents among cancer patients 
6. Intravenous Injection: Intravenous therapy, is the giving substances directly into 
a vein. The word intravenous simply means "within a vein". 
 
ASSUMPTION  
 
1. The patients would co operate and willing to participate in the study. 
2. The items included in the tool will be adequate and represent the measure of pain 
of cancer patients. 
3. The response to numerical rating scale would be the true measure of the pain  
4. Experienced by the intravenous administration of chemotherapeutic agents. 
5. Every client is unique and responds in a unique manner to pain. 
 
DELIMITATION 
 
1. Patients in a selected hospital only. 
2. Participants selected by non random method. 
3. Pain was measured by numerical rating scale. 
 
CONCEPTUAL FRAMEWORK 
 
The present study was aimed  at to evaluate the effect of cryotherapy on pain after the 
intravenous administration of chemotherapeutic agents among cancer patients. The conceptual 
framework of this study derived from gate control theory of pain. 
 
Gate control theory of pain: The gate control theory was initially proposed in 1965 by 
Melzack and wall. Gating mechanism can be found in substantia gelatinosa cells   
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Within dorsal horn of the spinal cord, thalamus, and limbic system.This theory states  
that pain is a function  of the balance between  information travel into the spinal cord through 
large nerve fibers and information travel travelling into the spinal cord through small nerve 
fibers.  
 
This theory suggested that the existence of gate that could facilitates  or inhibits the 
pain transmission is possible as the gate is controlled by the dynamic function  of the certain 
cells in the spinal cords dorsal horn.pain messages send along the spinothalamic and 
spnoreticular tracts can be inhibited by activity in large diameter alpha and beta fibers and 
chemical substance like endorphin secretions. Endorphins blocks pain signals. 
   
Pain perception: Is the point at which a person experience pain. In this study pain 
was measured in terms of pain scores by numerical rating scale. 
 
Intervention: In this study the intervention is cryotherapy. Cryotherapy is administered 
to the experimental group. cryotherapy stimulates  cold receptors  which send back impulses 
into the spinal cord via the posterior root and effectively Block out the pain pathways.Control 
group recevied conventional methods of nursing care without cryotherapy. 
 
Stimulation of pain receptors: Pain is transmitted through the body the nervous 
system when nerve endings detect damage to apart of the body. The nerves  transmit the 
warning through defined nerve pathways to the brain.,where the signals are interpreted as pain. 
In control group more stimulation of free nerve endings. In experimental group less stimulation 
of free nerve endings due to relaxation caused by cryotherapy. 
 
Traveling of pain impulses: Normally pain impulses are traveling through small short 
conducting fibers .Impulses from stimulation such as cold quickly transmitted by large fibers In 
 22
control group pain impulses will be will be conducted straight away by smll nerve fibers.which 
reach the gate of pain and open the gate,In experimental group where the patients receive 
cryotherapy.  
 
Pain gating mechanism: Refers to the means of reducing pain . It either regulates or 
blocks the pain impulses along ihe central nervous syetem. When gates are open pain 
impulses flow easily through pain path ways.when gates are closed the pain pathways blocked 
and pain impulses become reduced. 
 
Pain perception after cryotherapy was measured as mean reduction in pain It was 
hypothesized that the cryotherapy will make a significant difference in the pain after the 
intravenous administration of chemotherapeutic agents among cancer patients. 
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CHAPTER – II  
 
REVIEW OF LITERATURE 
 
According to cooper, "... a literature review uses as its database reports of primary or 
original scholarship, and does not report new primary scholarship itself. The primary reports 
used in the literature may be verbal, but in the vast majority of cases reports are written 
documents. The types of scholarship may be empirical, theoretical, critical/analytic, or 
methodological in nature. Second a literature review seeks to describe, summarise, evaluate, 
clarify and/or integrate the content of primary reports 
 
The main purpose of reviewing  relevant literatures to annotate and/or critique the 
literature in a subject area .Its ultimate goal is to bring the reader up to date with current 
literature on a topic and forms the basis for another goal, such as future research that may be 
needed in the area. 
 
Review of literature were organized under the following heading. 
  
1. Studies related to pain after the intravenous administration of chemotherapeutic agent. 
2. Studies related  to pain assessment. 
3. Studies related to cryotherapy in general. 
 
I. STUDIES RELATED TO PAIN AFTER THE INTRAVENOUS ADMINISTRATION  OF 
CHEMOTHERAPEUTIC AGENTS.  
 
Bristol [2011] conducted a randomized study to monitor the adverse effect of 
chemotherapy alone. Study was conducted in America. [n=442] the adverse effect of 
 25
chemotherapy alone the groups were anemia[19% and 13%]. Skin reactions including 
pain[11%] and six patients experienced injection related reactions.         
 
Lullmann.B.et al.[2010] conducted a study to  report the pain level  of children 
undergoing chemotherapy.cross over study was performed. The children received two 
punctures during their chemotherapy protocol.pain scores was measuring by using visual 
analogue scale. On the VAS pain scale, the mean pain was 2.3 (minimum 0, maximum 9.2) 
after 40 min and 1.9 (minimum 0, maximum 9.4) after 60 min according to the observations of 
the nurse and very similarly according to the parents' observations. The children expressed 
more pain after 40 min of EMLA[topical  anesthetic cream] [ application time (mean pain, 3.5) 
and a significant pain reduction after 60 min application time (mean pain 1.7). In this study 
children experienced less pain after 60 min application time. 
 
Lisa schalmeister.[2008] reported  a survey to determine  the incidence 
,management, and relieving  pain after the intravenous administration of chemotherapeutic 
agents.Two clinical trials were performed. Extravasation including pain was the most common   
problem of chemotherapeutic patients. Published incidence rates of chemotherapy 
extravasation range from 0.01% to6%. 
 
Kane .R. C., et. al.,[2007] conducted a study to report the adverse effect of 
anthracycline extravasation .They were found to be it was very problematic and most reports 
are anecdotal .The study was conducted in US.For the treatment of extravasation resulting 
from intravenous anthracycline chemotherapy they wanted to administer dexrazoxane 
hydrochloride injection.They found that dexrazoxane dose was effective to reduce the 
extravasation.  [n=57 patients]were experience extravasation from peripheral vein or central 
venous access with local swelling, severe pain,or redness 
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Espinosa E .et al [1996] conducted a study to assess the efficacy and toxicity  of the 
cisplatin and leucoverin combination  with advanced non small cell carcinoma. The dose 
consists of cisplatin 90mg/m and leucoverin on day  1 ,followed by oral LV 15mg/12 hrs on 
days 2 through 14.  The courses were repeated every 28 days for a minimum of three per 
patients.The study findings reveals that  the main side effects were skin toxicities, 
hematological, and gastrointestinal. The  skin toxicities  including pain was in 18% of the 
courses. Nausea and vomiting in 27% and diarrhea and epigastralgia in 13% each. The study 
findings reveals that this regimen cannot be recommend for the treatment for  advanced non 
small cell carcinoma due to its low response rate and its high toxicity. 
 
II. STUDIES RELATED TO PAIN ASSESSMENT                     
 
Roscetti A et al.,[2010] reported a study to examine the time to achieve pain relief in 
patients experienced periodic pain  breakouts despite baseline therapy with analgesics. This 
study pain intensity and wellbeing were assessed by a numerical rating scale and karnofsky 
performance scale, respectively.Adverse events and sleep pattern were recorded.[n=85 
patients] 14 experienced pain from non cancer diseases, and 71 had cancer related pain. 
Following stabilization of background pain, the intensity of daily pain improved; NRS decreased 
from baseline to day 14 for cancer (from 5.63 to 1.98) and non-cancer (from 8.00 to 1.00) 
groups (both p < 0.0001). Stabilization of background cancer-related or non-cancer pain with 
around-the-clock  immediate release of morphine therapy resulted in fewer intense episodic 
pain breakouts, which were more quickly managed with rescue-dose IR morphine 
 
Lisz w et al [2010] reported a prospective and descriptive  study to determine the 
difference in pain intensity following surgery as self reported by patients and assessed by 
nurses. The study was based on purposive sampling method. Conducted between  April 1 and 
July 31,2008 in the surgical wards of aregional teaching hospital in central Taiwan.Pain scores 
assessed by using numerical rating scale of 0 to 10. Two major findings included: (1) Pain 
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intensity scores self-assessed by patients ranged from 0 to 10. Scores assigned by nurses 
ranged between 0 and 6. Thus, patient scores were significantly higher than those assigned by 
nurses (p < .01). There was a discord in scoring between the two groups, with the gap ranging 
from 1 to 8. About 53.7% of nurses underestimated patient pain, while 31.5% overestimated it; 
and (2) The factor of nurse communication about pain with the patients had a negligible impact 
upon results. The study findings reveals that the nurses preferred using the numerical rating 
scale as the accurate pain score measurement.       
 
Piva . S R et.al[2005] conducted a study to assess the responsiveness of numerical 
rating scale in patients  with low back pain using a variety of methods. Cohort study was 
conducted among the patients in USA.Studies have assessed the reliability and validity of the 
numerical rating scale.Any change on the  numerical rating scale during 1 and 4 weeks was 
examined by calculating the mean change,standardized  effect size, responsiveness index. The 
majority of the patients had clinically meaningful after both 1 and 4 weeks of rehabilitation.The 
standard error of measure was equal to 1.02,corresponding to a minimum detectable change of 
2 points. The area under the curve at the 1 and 4 weeks follow up was 0.72[0.62,0.81] and 
0.92[0.86,0.97] respectively.The minimum clinically important difference at the 1 and 4 weeks 
follow up corresponded to a change of 2.2 and 1.5 points respectively. The study findings 
reveals that a 2- point changeon the numerical rating scale clinically meaningful change  that 
exceeds the bounds of measurement error.  
 
Aubrun et.al.[2003] conducted an observational study to assess the use of VAS and 
other pain scales by nurses in the postanaesthesia care unit  at universite pierreet Mary curie , 
paris. Among 600 patients included in the study. Nurses used the VAS in 53%, the numerical 
rating scale in 30%. The verbal rating scale in12%and the behavioural scale in 5%. In 43% of 
the assessment, nursed did not use the VAS. The most frequently cited reason was related to 
their preference for other methods .In 54% of the assessment,the reason for not using the VAS 
was relted to the patients, mainly when they were in too much pain to use it[22%] when the 
 28
patients was toomuch pain, the numerical rating scale was chosen in [54% ] and the 
behavioural scalein[ 27%]. There was no difference between young Patients  and elderly 
patients. The study findings reveals that although the VAS  is the standard method to assess 
pain  the nurse preferred using the numerical rating scle. 
 
Oden A et al.,[2000] conducted a study to report the applicability of three different pain 
scales. Such as visual analogue scale, graphic rating scale, and the numerical rating 
scale.Data werecollected in geriatric patients. At  a university hospital.An interview was 
conducted with 167  patients.[age=80years]. Patients reported  their experience of pain,ache or 
hurt[PAH]or other symptoms. The correlations were high and significant both between the 
ratings of the VAS, GRS and NRS (r = 0.78-0.92; p < 0.001) (alternative-forms reliability), and 
between the test and retesting (r = 0.75-r = 0.83; p < 0.001) (test-retest reliability). A logistic 
regression analysis showed that the probability to accomplish a rating on the pain scales 
decreased with advancing age of the patient. The study reveals that pain rating scales such as 
the VAS, GRS and NRS can be used to evaluate pain experience in geriatric patients. 
                            
 III. STUDIES RELATED TO CRYOTHERAPY IN  GENERAL 
 
Sabitha.P.B.,etal [2008]reported a study to assess the effectiveness of cryotherapy on 
arteriovenous fistula puncture related pain in hemodialysis patients. A convenience sample of 
60 patients [30 each in each experimental and control group] by using randomized control trial. 
Objective and subjective pain scoring  was done on two consecutive days.with cryotherapy for 
the experimental and without cryotherapy for the control group.The objective arteriovenous 
fistula puncture pain score on days 1 and 2 of hemodialysis patients on experimental group 
were found to be significantly reduced [p=0.001].so they conclude that cryotherapy is effective 
in reducing arteriovenous fistula puncture pain of hemodialysis patients. 
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Richard.Eustice.et al., [2008] reported  a study to assess the effectiveness of 
cryotherapy on relieving the symptoms of osteoarthritis. By using three randomized, controlied 
trials involving 179 patients with arthritis. The first of the three studies revealed that ice 
massage for 20 minutes ,a day ,5 days a week, for 2 weeks improved  musle strength in the 
leg. The second study showed that  patients using ice packs for 3 days  had no significant 
improvement in pain .  The third study indicated that cold packs applied  to the knee for 20 
minutes,10 minutes, resulted in decreased swelling compared to the control group. To 
summarize, the ice massage were useful for reducing knee swelling. 
 
              Mcdonough.S.M.,et al.,[2006] reported a study to assess the efficacy of cryotherapy 
protocol in the management of acute angle sprains. Using randomized controlled trials. Two 
treatment groups were selected. Standard ice application n=46 intermittent ice application 
n=43.One,two three four, six weeks after the injury  function, pain, swelling were recorded. 
Subjects treated with the intermittent protocol had significantly (p<0.05) less ankle pain on 
activity than those using a standard 20 minute protocol; however, one week after ankle injury, 
there were no significant differences between groups in terms of function, swelling, or pain at 
rest. Intermittent applications may enhance the therapeutic effect of ice in pain relief after acute 
soft tissue injury. 
 
 Laureano.Filho.,et al [2005]  reported the effectiveness of cryotherapy on reduction 
of pain ,swelling, and trismus after third molar extraction.n= 14 were the age group of 20 to 28 
years.The sample consists of  11 women and three men. The authors extracted two mandibular 
third molars at different times from each patient. Immediately after surgery, the patient 
underwent cryotherapy on one side for 30 minutes every one and one-half hours for 48 hours 
when he or she was awake. The patient did not receive cryotherapy on the other side. The 
authors performed clinical examinations to measure trismus and swelling before surgery, 
immediately after surgery and 24 and 48 hours after surgery.overall they  found significant 
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differences between the control and treated sides [p= < .05] cryotherapy was effective in 
reducing  post  operative swelling and pain.  
 
Heriuchih.H.,et.al.,[2004] conducted a study on continous local pooling for pain relief 
follow total hip arthroplasty among 40 patients . subjects were randomnly assigned in two 
group.cryotherapy was given 1-4 days following surgery .after that pain score was assessed. 
By using numerical rating scale.The findings were revealed that cryotherapy group pain level is 
significantly lower than the control group.  
 
 Finan et.al.,[2002] conducted a study to assess the effectiveness of cryotherapy on 
post operative pain in gynecologic patients undergoing laprotomy. [n=20] .experimental group 
consists of 13 patients.and control group consists of 13 patients.All patients underwent 
exploratory laprotomy. And received  post operative pain relief with intravenously administered 
analgesics. Data were analyzed by descriptive and inferential statistics. [P<0.05] The results 
shows that  the cryotherapy reduces the postoperative pain in gynecologica patients 
undergoing laprotomy. 
 
Allegaert.k.et. al .,[2003] reported a retrospective   study to document the systemic 
evaluation of pain in neonates on prescription of intravenous analgesics.in a level -111 
neonatal intensive care unit during a period before and after introduction of multidimensional 
pain scale.It was calculated in a group of infants.who all received cryotherapy for retinopathy of 
prematurity before and since introduction of pain evaluation.The number of prescribed vials 
increased from 3140+/-619[mean+/-SD ]to 5915+/-675[p<0.05].They conclude that systemic 
evaluation of pain increased awareness of treating and preventing pain in neonates even after 
correction of clinlical co variables. 
 31
CHAPTER – III  
 
METODOLOGY 
 
This chapter deals with description of the different steps undertaken by the investigator 
for the study. It includes the research design, variables, setting, Population, sample size, 
sample technique, sample criteria, description of tool, content validity, pilot study, data 
collection procedure  and plan for data collection procedure and plan for data analysis and  
ethical consideration. 
 
RESEARCH DESIGN 
                                 
The research approach in the study was quasi experimental design. To be specific, 
repeated measure time series with time series with control group design to evaluate the pain of 
intravenous administration of chemotherapeutic agents. 
 
There were two groups, experimental and control group. The control group was similar 
to experimental group with regard to age and selected factors. The experimental group 
included those patients who were different from control group  only with regard to receiving 
cryotherapy. Pretest and post test pain score was measured in both experimental and control 
group. Cryotherapy was administered to experimental group for 5-8 minutes at two intervals. 
For control  Group pretest and post test pain score was measured at two intervals 
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RESEARCH DESIGN NOTATION 
 
E  : O1 X1 O2  O3 X1 O4 
C   : O5-O6 ----- O7 -----O8 
 
E  : Experimental group 
C  : Control group 
X  : Intervention the cryotherapy 
-   : No intervention 
 O1,O3  : Pre test in experimental group 
 O5 ,O7  : Pre test in control group 
 O2 , O4 : Post test in experimental group 
 O6 ,O8        : Post test in control group. 
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TARGET POPULATION 
 
Patients receiving intravenous 
administration of 
chemotherapeutic agents  
ACCESSIBLE POPULATION 
 
Patients receiving intravenous 
administration of chemotherapeutic 
agents in Prethyasa Cancer Centre, 
Cherthala  
DATA COLLECTION 
 METHOD TOOL 
 
• Interview  
• Observation scheduling 
DATA ANALYSIS 
 
Descriptive and inferential 
FINDINGS 
REPORTING 
 
Dissertation  
SELECTED 
FACTORS 
&  
DISEASE 
FACTORS 
SAMPLING 
Purposive sampling 
Experimental 
Group 
(24) 
Control Group 
(22) 
Pre test  
 
01 , 03 
 
INTERVENTION 
Crytherapy  
Post test  
02 , 04 
Pre test  
 
05  , 07 
NO INTERVENTION 
Post test 
06-08 
Criteria measures  
Pain scores 
Fig. 2: DIAGRAMATIC REPRESENTATION OF RESEARCH DESIGN 
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SETTING OF THE STUDY 
 
It is essential for the researcher to consider the setting in which the experiment  is 
conducted. This study was conducted in the Prethyasa cancer institute and research centre at 
Green gardens hospital, Cherthala. 
 
VARIABLES 
 
The two categories of variables included were, 
• Independent variable : Cryotherapy 
• Dependent variable : Pain  
 
POPULATION 
 
 Target population refers to the population that researcher wishes to make a  
Generalization. In this study the target population were the patients receiving Intravenous 
administration of chemotherapeutic agents. 
 
The accessible population were patients those who receiving intravenous 
administration of chemotherapeutic agents admitted in Prethyasa  institute of cancer and 
research centre, Green Gardens Hospital Cherthala. 
 
SAMPLING TECHNIQUE 
 
           In this study the investigator selected the patients they were receiving  Intravenous 
administration of chemotherapeutic agents by purposive sampling method. 
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SAMPLING CRITERIA 
 
a. Inclusion Criteria:  
Inclusion criteria are characteristics  that each sample element must possess 
to be included in the sample. It specified the patients  
• Diagnosed with cancer. 
• Receiving chemotherapy. 
• Of both sexes 
• Who were above 20 years. 
• Those  who were willing to participate the study. 
• Who were present at the time of data collection. 
• Those who were able to understand Malayalam. 
 
b. Exclusion Criteria 
It specified the patients 
• who were not oriented and conscious. 
• who refused to participate in the study. 
• who could not understand  or speak Malayalam. 
 
SAMPLE SIZE 
 
Sample is subset of population that has been selected to represent the population of 
interest. The sample for the study was patients they were receiving intravenous administration 
of chemotherapeutic agents. The sample size for this study was arbitrarily decided to be 60. 
Finally a sample of 24 patients in experimental group and 22  patients in control group were 
included in the study. Other patients did not turn up for the second dose within the prescribed 
time. 
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DEVELOPMENT  OF TOOL 
 
The investigator  prepared  and   developed an  interview schedule as a tool for   
Present study after exploring all sources  of information like extensive library Search, internet 
sources and consultation with experts. Numerical pain rating scale was used to assess the 
pain. Items regarding background factors and disease factors were developed by the 
investigator. 
 
DESCRIPTION OF TOOL 
 
The study tool consisted of three sections; 
Section I : Back ground factors. 
Section II  : Disease related factors. 
Section III : Numerical rating scale on pain. 
 
Section I: This section consisted items regarding background factors like age, sex, 
educational status, marital status, occupational status, any bad habits ,dietary habits, and any 
family history of cancer. 
 
Section II: This section consisted items regarding disease related factors such as 
diagnosis, stage of cancer, treatment option, purpose of treatment, category of 
chemotherapeutic agents, developing complication after the administration, drugs received at 
present,  name of the solution, Body mass index, site of intravenous injection, pain experienced 
because of the disease, pain controlled through medication, other associated illness, sleep 
pattern at night, and observation of the site before treatment. 
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Section III: This section consisted  of a scale ranging from 0-10 to assess the pain of 
intravenous administration of chemotherapeutic agents. The response ranged from “no pain” at 
all-0 to “severe pain-10.for the purpose of the study the average of two pretest and average of 
two post test were considered as pretest and post test respectively.  
 
VALIDITY OF THE TOOL 
 
The tool developed  by  the investigator  was sent along with the request for validation 
to five experts  including two oncologists  and three nursing experts. The experts were 
requested to check for the relevance, sequence, adequacy of language of the tool. The tool 
was modified according to expert’s opinion. The  items with 100% agreement were  in the tool. 
A few were modified and retained in the tool. 
 
PILOT STUDY 
 
Feasibility of the study was done among ten patients they were receiving intravenous 
administration of chemotherapeutic agents  after obtaining permission  from the authority. The 
setting was Prethyasa institute of cancer and research centre. Cherthala. It helped the 
researcher to ascertain the feasibility of the designed methodology.  
 
RELIABILITY 
 
The reliability of the instrument was established by inter rater reliability. The instrument 
was administered to 10 individuals simultaneously by one nursing personnel and  the 
investigator. The tool was found to be reliable for the study. The obtained  reliability co-efficient 
r=0.86, was high. 
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CRYOTHERAPY INTERVENTION 
 
The investigator prepared a cryotherapy pack ,as specified ,A cryotherapy intervention 
guide was prepared after extensive search of books, journals, research and non research 
publications and websites  on the internet. The steps for cryotherapy  consists of preparatory 
phase ,action phase, and Post cryotherapy phase.as specified in appendix v “A cryotherapy 
intervention guide” 
 
This therapy will be administered by the investigator immediately after the intravenous 
administration of chemotherapeutic agents with adequate explanations. This procedure takes  
5 to 8 minutes. 
 
VALIDITY OF CRYOTHERAPY 
 
The steps involved in the cryotherapy was demonstrated by the investigator before four 
nursing experts. Due corrections were incorporated. Thus validity of the intervention was 
established. 
 
DATA COLLECTION 
 
The data were collected for 4 weeks from 7th October 2010 to  31 October 2010. 
Permission was sought and obtained from authorities of Prethyasa institute of cancer and 
research centre, Cherthala. Based on sample selection criteria using purposive sampling 
method samples were selected.The study purpose and method were explained to individual 
participants and informed consent was obtained.   
 
The information regarding background factors  and disease related factors were  
collected from 46 samples  by interviewing them and  observing health records.Pain was 
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measured using numerical rating scale from both the experimental and control group.with an 
interval of 10 minutes.The intervention cryotherapy was for experimental group.The evidence of 
intervention and pain were marked in a grid.Intervention was done at the bedside.The 
experiment was repeated twice during two consecutive doses. 
  
PLAN FOR  DATA  ANALYSIS 
 
The data were edited, coded and entered in Excel sheet. The data were analyzed 
using SPSS version 10. A probability of less than 0.05 was considered to be significant. 
 
The data were analyzed as follows; 
1. Background factors of patient and disease related factors in experimental and 
control group were analyzed using descriptive statistics and chi-square. 
2. Data on effectiveness of cryotherapy on pain before and after the intravenous 
administration of chemotherapeutic agents among the cancer patients in 
experimental group were analyzed  using paired t test. 
3. Data to compare the mean difference on pain among cancer patients between the 
experimental and control group were analyzed using independent sample t test. 
4. Data on association between the mean difference on pain  and selected factors 
among the cancer patients in experimental group were analyzed using linear 
regression. 
 
ETHICAL CONSIDERATION 
 
The study objective, intervention and data collection were approved by the research  
and ethical committee of the institution. Main study was conducted after obtaining permission 
from the Medical superintendent of green gardens hospital. Informed consent was obtained 
from the cancer patients. No routine care was altered or withheld. 
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CHAPTER – IV 
 
DATA ANALYSIS AND INTERPRETATION 
 
The analysis and interpretation of data of this study is based on the data collected from 
the cancer patients. The data collected were edited, tabulated, and analyzed Using SPSS 
version 17. A probability value of less than 0.05 was considered to be significant. Findings were 
presented in the form of tables and diagrams. 
 
The objectives of study were; 
1. To assess the effectiveness of cryotherapy on pain before and  after the 
intravenous administration of chemotherapeutic agents among the cancer patients 
in experimental group. 
2. To compare the mean difference on pain  among the cancer patients between the 
experimental and control group.  
3. To test the association between the mean difference on pain and selected factors 
among the cancer patients in experimental group. 
 
The data analyzed were presented as follows; 
 
Section – I : Data on background factors and disease factors of cancer patients in 
the experimental and control group. 
Section – II  :   Data on pain  among the cancer patients in experimental group. 
Section – III : Data on mean difference on pain between the experimental and 
control group. 
Section – IV  : Data on association between the mean difference on pain and 
selected factors among the cancer patients in experimental group. 
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SECTION – I: DATA ON BACKGROUND FACTORS AND DISEASE FACTORS 
OF CANCER PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP. 
 
TABLE – 1 
Frequency and percentage distribution of cancer patients in the experimental and 
control group regarding their background factors. 
 (n = 46) 
Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-square 
Test 
Age 
     31-40yrs 
     41-50yrs 
     50-above 
 
4 
9 
11 
 
17 
37 
46 
 
4 
11 
7 
 
18 
50 
32 
 
1.004 
[p=.605] 
[NS] 
Educational status 
     Primary school 
     Secondary school 
     Higher secondary school 
     Graduate 
 
11 
10 
2 
1 
 
46 
42 
8 
4 
 
12 
6 
4 
0 
 
54 
25 
28 
0 
 
2.628 
[.453] 
[NS] 
Employment status 
     Employed 
     Unemployed 
 
19 
5 
 
 
79 
21 
 
20 
2 
 
91 
9 
 
1.227 
[p=.418] 
[NS] 
Marital status 
     Married 
     Unmarried 
  
 
24 
0 
 
100 
0 
 
22 
0 
 
100 
0 
 
 
Constant 
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Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-square 
Test 
Family history of cancer 
     Yes 
     No 
 
11 
13 
 
46 
54 
 
13 
9 
 
59 
41 
 
1.511 
[p=.470] 
[NS] 
 
Table -1 reveals the frequency and percentage distribution of cancer patients in the 
experimental and control group regarding their  back ground factors. 
  
It was inferred that majority of cancer patients in experimental group were 50 above 
age group 11[46%],had primary school education 11[46%],were employed 19[79%],were 
married 24[100%],had no family history 13[54%]. 
 
Also in control group majority of cancer patients were 41-50 years age group 
11[50%],had primary school education 12[50%],were employed 20[91%],were married 22 
[100%],had a family history13[59%].  
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Figure 3 reveals the frequency and percentage distribution of sex of cancer patients. 
 
 Both the sexes of cancer patients were equal distribution in experimental group 12 
(50%). Majority of cancer patients were female 13 (59%) in control group. 
EXPERIMENTAL GROUP
12 (50%) 
12 (50%) 
Male
Female
 
CONTROL GROUP
13 (59%)
9 (41%) 
Male
Female
 
Fig. 3: FREQUENCY AND PERCENTAGE DISTRIBUTION OF 
SEX OF CANCER PATIENTS 
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Figure 4 reveals the frequency and percentage distribution of habits of cancer patients. 
 
 Majority of cancer patients were not having any habits 12 (50%) in experimental group. 
Majority of cancer patients were both smoking and alcoholism 8 (36%) in control group. 
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Fig. 4: FREQUENCY AND PERCENTAGE DISTRIBUTION OF HABITS OF CANCER 
PATIENTS. 
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Figure 5 reveals the frequency and percentage distribution of dietary habits of cancer patients. 
 
 Majority of cancer patients were non-vegetarian 23 (96%) in experimental group and 2 
(26%) in control group. 
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Fig. 5: FREQUENCY AND PERCENTAGE DISTRIBUTION OF DIETARY HABITS OF 
CANCER PATIENTS. 
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TABLE – 2 
Frequency and percentage distribution of cancer patients in the experimental and 
control   group regarding their disease related factors. 
 (n = 46)  
Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-
square 
Test 
Stage of cancer ? 
Cancer in situ 
Tumor limited to the tissue of origin 
Limited local spread 
Extensive local and regional spread. 
Metastasis 
 
1 
7 
11 
3 
2 
 
4 
29 
46 
13 
8 
 
1 
6 
6 
9 
0 
 
5 
27 
27 
40 
0 
6.473 
[p=.167] 
[Ns] 
 
Treatment option ? 
Radiation + surgery  
+ chemotherapy. 
Radiation  chemotherapy. 
 
12 
 
12 
 
50 
 
50 
 
11 
 
11 
 
50 
 
50 
.000 
[p=1.000] 
[NS] 
Purpose of treatment. 
Curative 
Palliative 
 
19 
5 
 
79 
21 
 
13 
9 
 
59 
40 
2.185 
[p=.202] 
[Ns] 
Category of chemotherapeutic 
drug. 
Cell cyclic specific 
Cell cycle non specific 
Miscellaneous 
Both cell cyclic specific and non 
specific. 
 
 
8 
13 
2 
1 
 
 
33 
54 
8 
4 
 
 
10 
10 
1 
1 
 
 
45 
45 
5 
5 
 
 
.862 
[p=.835] 
[NS] 
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Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-
square 
Test 
How long you are receiving 
chemotherapy ? 
<1 year 
1-2 year 
 
 
24 
0 
 
 
100 
0 
 
 
21 
1 
 
 
95 
5 
 
1.115 
[p=.478] 
[NS] 
Any  complications after 
chemotherapy?  
Extravasation  
Vomiting 
Headache 
Any other------ 
Nil 
 
 
0 
9 
8 
4 
3 
 
 
0 
38 
33 
17 
13 
 
 
1 
6 
10 
4 
1 
 
 
5 
25 
45 
18 
5 
2.740 
[p=.602] 
[NS] 
Specify the name of the solution? 
Normal saline 
Dextrose. 
 
18 
6 
 
75 
25 
 
14 
8 
 
63 
36 
.700 
[p=.525] 
[NS] 
Body mass index? 
Malnourished 
Normal 
Obese. 
 
5 
11 
8 
 
21 
46 
33 
 
3 
15 
4 
 
13 
68 
18 
 
2.366 
[p=306] 
[Ns] 
Size of the needle 
18 gauge 
20 gauge 
22 gauge 
24 gauge 
 
 
24 
0 
0 
0 
 
100 
0 
0 
0 
 
20 
1 
1 
0 
 
90 
4 
4 
0 
2.281 
[p=.320] 
[Ns] 
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Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-
square 
Test 
Site of intravenous injection 
Radial 
Ulnar  
Brachial 
Metacarpal. 
 
7 
11 
0 
6 
 
29 
46 
0 
25 
 
8 
2 
7 
5 
 
36 
9 
32 
22 
2.965 
[p=.397] 
[Ns] 
Pain experienced because of the 
disease? 
Mild 
Moderate 
Sever 
 
 
7 
8 
9 
 
 
29 
33 
38 
 
 
5 
6 
11 
 
 
22 
25 
50 
 
.733 
[p=.693] 
[NS] 
Pain controlled through 
medication? 
Fully controlled  
Partially controlled 
Un controlled 
 
 
0 
20 
4 
 
 
0 
83 
17 
 
 
1 
17 
4 
 
 
5 
77 
18 
1.158 
[p=.560] 
[NS] 
Other associated illness? 
Hypertension 
Diabetes mellitus 
Nil 
Both diabetes and hypertension 
 
7 
6 
6 
5 
 
29 
25 
25 
20 
 
7 
11 
3 
1 
 
31 
50 
13 
5 
 
 
5.193 
[p=.268] 
[NS] 
Sleep pattern at night? 
Disturbed 
Adequate 
Can’t sleep at night. 
 
11 
11 
2 
 
46 
46 
8 
 
7 
14 
1 
 
31 
63 
4 
 
1.498 
[p=.473] 
[NS] 
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Experimental 
Group (n = 24) 
Control 
Group (n = 22) Background Factors 
No % No % 
Chi-
square 
Test 
Observation of the site before 
treatment? 
Erythema  
Swelling 
Induration  
Black discolouration  
Nil 
 
 
4 
8 
1 
8 
3 
 
 
17 
33 
4 
33 
13 
 
 
3 
17 
0 
2 
0 
 
 
13 
77 
0 
9 
0 
 
 
10.917 
[p=.028] 
[NS] 
 
 
Table 2 reveals the frequency and percentage distribution of cancer patients in the 
experimental and control group regarding their disease factors. 
 
It was inferred that majority of cancer patients in experimental group were tumor limited 
local spread 11 [46%],had received both,radiation+surgery+chemotherapy and radiation 
+chemotherapy12[50%],were taking curative treatment19[79%],were receiving cell cycle non 
specific 13[54%],were receiving chemotherapy <1 year 24[100%],had developed complication 
after chemotherapy vomiting 9[38%],had received normal saline 18[75%],were normal  body 
mass index 11 [46%], had a needle size of gauge 18 24[100%],had received the injection site 
of ulnar 11[46%],had experienced pain because of the disease as severe 9[38%],had pain 
controlled through medication as partially controlled 20[83%]  Had associated illness  of 
hypertension 7[29%],had both disturbed and adequate sleep pattern 11[46%],had developed 
both swelling and black discolouration 8[33%]. 
 
Also in control group majority of cancer patients were extensive local and regional 
spread 9[40%]had received both radiation+surgery+chemotherapy and radiation+ 
chemotherapy11[50%],were taking curative treatment 13[59%],were receiving both cell cycle 
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specific and cell cycle nonspecific 10[45%], were receiving chemotherapy <1year 21[95%], had 
developed complication after chemotherapy as headache 10[45%], had received normal saline 
14[63%] were normal  body mass index 15[68%] had a needle size of 18 gauge 20[90%] had 
received the injection site of radial 8[36%],had experienced pain because of the disease as 
severe 11[50%],had pain controlled through medication as partially controlled 17[77%],had 
associated illness of diabetic  mellitus 11[50%],had adequate sleep pattern 14[63%],had 
developed swelling17[77%]before the treatment. 
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Figure 6 reveals the frequency and percentage distribution of type of cancer.  
 
 Majority of cancer patients were Ca Breast 6 (25%) in experimental group and Ca 
Ovary and Ca Liver 3 (14%) in control group. 
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Fig.6: FREQUENCY AND PERCENTAGE DISTRIBUTION OF TYPE OF CANCER. 
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Figure 7 reveals the frequency and percentage distribution of number of drugs received at 
present of cancer patients. 
 
 Majority of cancer patients received two drug 23 (96%) in experimental group and 17 
(77%) in control group. 
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Fig. 7: FREQUENCY AND PERCENTAGE DISTRIBUTION OF NUMBER OF DRUGS 
RECEIVED OF CANCER PATIENTS. 
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Figure 8 reveals the frequency and percentage distribution of number of times Intravenous 
injection administered per day of cancer patients. 
 
 Majority of cancer patients were administered Intravenous injection once 24 (100%) in 
experimental group and 20 (90%) in control group. 
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Fig. 8: FREQUENCY AND PERCENTAGE DISTRIBUTION OF NUMBER OF TIMES 
INTRAVENOUS INJECTION ADMINISTERED PER DAY OF CANCER PATIENTS. 
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Figure 9 reveals the frequency and percentage distribution of fluids supplementation of cancer 
patients. 
 Majority of cancer patients were received fluids 24 (100%) in experimental group and 
21 (95%) in control group. 
EXPERIMENTAL GROUP
24 (100%) 
0 (0%) Yes
No 
 
EXPERIMENTAL GROUP
2 (9%)
21 (95%) 
Yes 
No
 
Fig. 9: FREQUENCY AND PERCENTAGE DISTRIBUTION OF FLUIDS 
SUPPLEMENTATION OF CANCER PATIENTS. 
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SECTION – II: DATA ON PAIN AMONG THE CANCER PATIENTS IN 
EXPERIMENTAL GROUP. 
 
For the purpose of the study the following null hypothesis was stated, 
H01   :  There will be no significant difference in pain before and after cryotherapy  
among patients with cancer in experimental group. 
 
TABLE – 3 
Mean, SD, mean difference and “t “value on pain before and  after cryotherapy in 
experimental group between 1st and 2nd intervention 
                                                                                                       (n = 46) 
Test Intervention  mean SD 
Mean 
difference 
‘t ’value 
(p) 
Pre Test 5.83 2.18 
Post Test 
1st  
4.13 
 
2.01 
1.71 
8.377 
[P=.001] 
(S) 
Pre Test 6.25 1.51 
Post Test 
2nd 4.58 1.50 1.67 
9.405 
[p=.001] 
(S) 
 
Table 3  shows the mean, standard deviation, mean difference and “t” value of pain 
after cryotherapy in experimental group between the 1st and 2nd  intervention. 
 
There was a significant difference in pain after cryotherapy in 1st and 2nd doses.t=8.377 
[p<0.05],  t=9.405 [p<0.05]  respectively. Therefore null hypothesis was rejected. 
 
It was inferred that cancer patients in experimental group had significant reduction in 
pain after cryotherapy. And it was found to be  effective. 
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SEDTION III : DATA ON MEAN DIFFERENCE ON PAIN BETWEEN THE 
EXPERIMENTAL AND CONTROL GROUP    
 
 For the purpose of the study the following null hypothesis was stated, 
H02   :  There will be no significant difference in the mean difference  of pain among cancer  
patients  between the  experimental and control group 
 
TABLE – 4 
Mean difference, SD, difference in mean difference and “ t value on pain between 
the experimental and control group. 
Group Intervention 
Mean 
difference 
SD 
Difference 
in mean 
difference 
‘t’value 
Experimental  
group 
1st 1.71 1.00 
Control group 1st 0.50 0.60 
1.21 
4.920 
[p=.001] 
(S) 
Experimental 
group 
2nd 1.67 0.87 
Control group 2nd 0.36 0.49 
1.30 
5.025 
[p=.001] 
(S) 
 
Table 4 shows the mean difference, SD, difference in mean difference ,and “t” value of 
pain among cancer patients between experimental and control group.  
The mean difference on pain during 1st and 2nd intervention among cancer patients in 
experimental and control group was significant. t=4.920[p<0.05],t=5.025 [p<0.05] respectively.  
There was a significant reduction in pain after cryotherapy in 1st and 2nd intervention. 
Therefore the null hypothesis was rejected.   
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SECTION – IV: DATA ON ASSOCIATION BETWEEN THE MEAN 
DIFFERENCE ON PAIN AND SELECTED FACTORS AMONG CANCER 
PATIENTS IN EXPERIMENTAL GROUP. 
 
TABLE – 5 
Linear regression regarding association between mean difference in pain and 
background factors among cancer patients in experimental group. 
 
CI  95% 
Variables Beta “t” p 
Lower Upper 
Age -.093 -.667 .625[NS] -1.754 1.579 
Sex .270 .408 .753[NS] -11.209 11.952 
Educational 
Status 
-.442 
 
-1.217 
.438[NS] 
 
-4.421 3.648 
Employment status .051 .123 .922[NS] -8.876 9.050 
Any bad habits -.637 -2.741 .233[NS] -2.397 1.546 
Dietary habits -.228 -1.090 .473[NS] -9.965 8.390 
Family history of any cancer 
.922 5.545 .114[NS] -1.437 3.662 
 
Table – 6 shows that beta value, “t” value, 95% confidence interval regarding pain and 
background factors among cancer patients in experimental group based on linear regression.  
 
The background variables such as age, sex, educational status, employment status 
,any bad habits, dietary habits, any family history of cancer, were  not significantly associated 
with pain among cancer patients[p>0.05]  
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TABLE – 6  
Linear regression regarding association between mean difference in pain and 
disease factors among cancer patients in experimental group. 
 
95% CI  
Variables 
Beta 
Value 
“t” P 
Lower Upper 
Type of cancer .010 .014 .991[NS] -1.467 1.471 
Stage of cancer .918 1.559 .363[NS] -4.747 6.074 
Treatment option .585 2.244 .267[NS] -3.757 5.369 
Purpose of treatment -.928 -1.438 .387[NS] -15.507 12.354 
Category of chemotherapeutic 
agent 
.132 .377 .770[NS] -3.984 4.228 
Any complication .162 .784 .577[NS] -1.327 1.501 
How many drugs are you 
received 
.324 .526 .692[NS] -25.832 28.065 
Specify the name of the solution 1.096 2.171 .275[NS] -8.464 11.953s 
Body mass index .251 1.087 .474[NS] -2.547 3.023 
Site of intravenous injection .044 .107 .932[NS] -3.141 3.194 
Pain experienced because of the 
disease 
.164 
.606 
 
.653[NS] -2.778 
3.057 
 
Pain controlled through 
medication 
-.429 -1.676 .343[NS] -6.803 5.217 
Other associated illness -.734 -2.092 .284[NS] -1.692 1.214 
Sleep pattern at night .323 .581 .665[NS] -7.344 8.048 
Observation of the site before 
treatment? 
.112 .278 .827[NS] -2.555 2.670 
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Table – 7 shows that beta value, “t” value, 95% confidence interval regarding pain and 
disease factors among cancer patients in experimental group based on linear regression.  
 
The disease factors such as type of cancer, stage of cancer ,treatment option ,purpose 
of treatment, category of chemotherapeutic agent, any complication after chemotherapy, 
number  of drugs received, specify the name of solution? body mass index ,,site of intravenous 
injection, pain experienced because of the disease, pain controlled through medication, other 
associated illness, sleep pattern at night, observation of the sight before treatment? 
respectively were not significantly associated with pain among cancer patients[p>0.05] 
 
Therefore it was inferred that  background and disease factors are not  influenzed in 
the reduction of pain among cancer patients in experimental group. 
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CHAPTER – V 
 
SUMMARY, FINDINGS, DISCUSSION, IMPLICATIONS, 
LIMITATIONS,  RECOMMENDATIONS AND CONCLUSION 
 
The essence of research project  is based on study findings, limitations, interpretations 
of the result and recommendations that incorporate  the study implications. It  also gives to the 
results obtained in this study. 
 
SUMMARY 
The prime aim of the study was to assess pain before and after cryotherapy among 
cancer patients. 
  
The objectives of the study were, 
1 To assess the effectiveness of cryotherapy on pain before and  after the 
intravenous administration of chemotherapeutic  agents among the cancer patients  
in experimental group. 
2 To compare the mean difference on pain among the cancer patients between the 
experimental and control  group. 
3 To test the association between the mean difference on pain and selected factors 
among the cancer patients in experimental group. 
 
The review of literature enabled the investigator to develop conceptual framework, tool 
and methodology for the study. Literature review was done as follows studies related to pain of 
intravenous administration of chemotherapeutic agents,studies related to pain assessment. 
studies related to cryotherapy in general. 
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The conceptual framework adopted for the present study was based on the gate 
control theory Melzack and Wall [1965].This model helped the investigator to assess the effect 
of cryotherapy on pain among chemotherapeutic patients.Cryotherapy is used as pain relieving 
measures. 
 
The present study was quasi experimental, Independent variable in this study was 
cryotherapy and dependent variable in this study was pain after intravenous administration of 
chemotherapeutic agents. Associate variable for this study were background factors and 
disease related factors. 
 
The tool developed and used for the study was an interview schedule. Numercal rating 
scale was used to assess the pain. The content validity of the tool was established by 5 
experts. The reliability of the tool was established by inter rater reliability computed reliability 
coefficient r=0.86 was high. 
 
The main study was conducted in prethyasa institute of cancer and research centre 
cherthala. Prior permission from the authorities was sought and obtained.Individual informed 
consent was taken from study sample. The study sample were selected by purposive sampling 
method based on sample selection criteria. 
 
A total of 46 patients [24 experimental group,22 control group] where selected. Data 
were  collected from both the experimental and control group. The intervention cryotherapy was 
given 5-8 minutes for experimental group. Pretest and post test pain score was measured. 
Intervention was done at the bedside. All the patients received their routine care. The collected 
data were analyzed and interpreted based on objective using spss package[version17] at 0.05 
level of significance. 
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CHARACTERISTICS OF STUDY SAMPLES 
 
Majority of cancer patients in experimental group were 50 above years 11 [46%] were 
both the sexes equal ,had primary education 11 [46%] had employed 19 [79%] were married 24 
[100%] had no other bad habits 12 [50%] were nonvegeterian 23 [96%] had no family history of 
cancer 13 [54%] 
 
Also in control group majority of cancer patients were 41 to 50 years 11 [50%] were 
females 13 [59%] had primary education 12 [54%]had employed 20 [91%] were married  22 
[100%] had bad habits of both smoking and alcoholism 8[36%]were nonvegetarian 22 [96%] 
had family history of cancer 13 [59%] 
 
FINDINGS 
  
The major findings of the study presented under following headings based on the 
objectives of the study. 
 
Objective -1:  To assess the effectiveness of cryotherapy on pain before and  after the 
intravenous administration of chemotherapeutic agents among the cancer patients in 
experimental group 
  
• There was a significant difference in pain after cryotherapy in 1st and 2nd doses.t=8.377 
[p<0.05],  t=9.405 [p<0.05]  respectively.Therefore null hypothesis was rejected 
 
Objective -2: To compare the mean difference on pain  among the cancer patients 
between the experimental and control group.  
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• The mean difference on pain during 1st and 2nd intervention among cancer patients in 
experimental and control group was significant. t=4.920[p<0.05],t=5.025 [p<0.05] 
respectively. There was a significant reduction in pain after cryotherapy in 1st and 2nd 
intervention. 
 
Objective -3: To test the association between the mean difference on pain and selected 
factors among the cancer patients in experimental group. 
 
• There was no significant association between the mean difference and the selected 
variables such as age ,sex ,educational status , Employment status ,any bad habits 
,Dietary habits ,family history of cancer , type of cancer, stage of cancer , purpose of 
treatment,Category of chemotherapeutic agents ,any complication developed after the 
administration of drug ,how many drugs are you received at present , specify the name 
of the solution , Body mass index ,site of intravenous injection , pain experienced 
because of the disease ,pain controlled through medication , Other associated illness , 
sleep pattern at night ,observation of the sight before treatment ,among experimental 
group [p>0.05] were not significantly associated with pain among cancer patients. 
 
DISCUSSION 
 
The results of the study were discussed based on the finding of the study. 
  
Finding 1: To assess the effectiveness of cryotherapy on pain before and after the 
intravenous administration of chemotherapeutic  agents among the cancer patients  in 
experimental group.  
 
• There was a significant difference in pain after cryotherapy in 1st and 2nd doses.t=8.377 
[p<0.05],  t=9.405 [p<0.05]  respectively.Therefore null hypothesis was rejected 
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This findings were supported by the related studies conducted by Sabitha P.B  et.al., a 
study to assess the effectiveness of cryotherapy on arteriovenous fistula puncture related pain 
in hemodialysis patients .The  objective pain score of hemodialysis patients on experimental 
group were found to be significantly reduced. [p=0.001].Laureano et.al., reported  the 
effectiveness of cryotherapy on reduction of pain,swelling,and trismus after third molar 
extraction [p<.05] and it was found that cryotherapy was effective in reducing pain. 
 
Finding 2: To compare the mean difference on pain among the cancer patients between 
the experimental and control  group.  
 
• The mean difference on pain during 1st and 2nd intervention among cancer patients in 
experimental and control group was significant. t=4.920[p<0.05],t=5.025 [p<0.05] 
respectively. There was a significant reduction in pain after cryotherapy in 1st and 2nd 
intervention. 
 
The above findings of the study was  supported by the related study conducted Allegaert.k 
et.al., intravenous injection of pain in neonates on prescription of analgesics. The number of 
prescribed vials increased from 3140+/-619[mean+/-SD to 5915+/-675[p<0.05]children who 
received cryotherapy.  
 
Finding 3: To test the association between the mean difference on pain and selected 
factors among the cancer patients in experimental group. 
 
• There was no significant association between the mean difference and the selected 
variables such as age ,sex ,educational status , Employment status ,any bad habits, 
Dietary habits , family history of cancer , type of cancer, stage of cancer , purpose of 
treatment, Category of chemotherapeutic agents ,any complication developed after the 
administration of drug ,how many drugs are you received at present , specify the name 
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of the solution , Body mass index ,site of intravenous injection , pain experienced 
because of the disease ,pain controlled through medication , Other associated illness , 
sleep pattern at night ,observation of the sight before treatment ,among experimental 
group [p>0.05] were not significantly associated with pain among cancer patients. 
 
IMPLICATIONS 
 
The study had implications, guidelines and suggestions for nursing practice, nursing 
education, nursing administration and nursing research. 
 
Nursing Practice 
• Cryotherapy is an effective measure to block the pain pathway. Research 
evidence shows that cutaneous application is an independent nursing 
intervention to minimize the pain .Nurse should effectively  use this measure to 
alleviate the intravenous administration of chemotherapeutic  agents. 
• Nurses plan the goal of nursing management and enhance the nurse patient 
relationship and sense of well being to the patient through the development of 
mutually agreed goals. 
•  Cryotherapy should be considered as an integral part of pain relief 
management in nursing. It numbs pain, reduces joint swelling, constricts blood 
vessels, and block nerve impulses to the affected area. 
 
Nursing Education 
• Nurse educators should encourage nursing students to utilize cryotherapy as 
measure for reducing the pain of intravenous administration of injections. 
• In service education programme should be conducted for nursing personnel and 
help nurses to gain knowledge about cryotherapy. 
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Nursing Administration 
• Nursing departments should have policy decision to use cryotherapy as an 
essential nursing activity to reduce the intravenous administration of 
chemotherapeutic agents. 
• Administration must provide adequate cryotherapy packs and materials for 
effective nursing care. 
 
Nursing Research 
• The study will be a valuable reference material for future researchers. 
• The findings of the study would help to expand the scientific body of 
professional knowledge upon which further researches can be conducted. 
• Cryotherapy may be studied more scientifically and used as a specific nursing 
intervention. 
 
LIMITATIONS 
 
• Random selection was not done. 
• Experience level of investigator. 
• Study was done on limited sample. 
• Procedure takes time, consuming the nursing hours. 
 
RECOMMENDATIONS 
 
• Randomized controlled trial can be done. 
• Similar study can be conducted for a larger group. 
• Effect of cryotherapy for a prolonged period can be studied 
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CONCLUSION 
 
The following conclusion was drawn from the following study. The cancer patients in 
the experimental group had reduction in pain after the intravenous administration of 
chemotherapeutic agents by administering cryotherapy. The future of this field of nursing 
science promises to be one of the rapid significant growth. The results of which will directly 
influence patient care in the aspects of evidence based nursing care. 
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APPENDIX – I 
 
LETTER SEEKING PERMISSION FOR CONTENT VALIDITY 
 
From, 
30093601 
II year M.Sc (Nursing), 
Annai J K K Sampoorani Ammal College of Nursing 
Komarapalayam, 
Namakkal district. 
To, 
 
 
 Through 
The Dean, 
Annai J K K Sampoorani ammal College of Nursing, 
Komarapalayam, 
Namakkal District. 
 
Respected  Madam/sir 
 
        Sub: Letter requesting consent to validate the tool. 
            
 I am 30093601, II year M.Sc., Nursing student of Annai JKK Sampoorani Ammal 
College of Nursing Komarapalayam, under the Tamil Nadu Dr. M G R Medical University, 
Chennai. 
As a partial fulfillment of M.Sc Nursing Programme, I am conducting  “A study to 
assess the effectiveness of cryotherapy on pain after  the intravenous  administration of 
chemotherapeutic agents among  patients with cancer in  selected hospital, Cherthala, 
Alappuzha”. Herewith I am sending the tool for content validity for your expert opinion. I 
humbly request yourself to spare a little of your valuable time for me which I remain ever 
grateful to you.                                 Thanking you 
 
Place:   Komarapalayam,                         Yours sincerely                  
Date:             (30093601) 
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APPENDIX – II   
 
CONTENT VALIDITY CERTIFICATE 
 
I hereby certify that I have validated the tool of 30093601, II M.Sc (Nursing), student of 
Annai J.K.K.M Samporani Ammal College of nursing, Komarapalayam, who is undertaking the 
following study on “A  study to assess the effectiveness of cryotherapy on pain after  the 
intravenous  administration of chemotherapeutic agents among  patients with cancer in  
selected hospital, cherthala, Alappuzha” 
 
 
Place: Komarapalayam                                              Signature of the expert 
Date:                                                                            
                                                                                            Designation  
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APPENDIX – III  
LIST OF EXPERTS 
 
1. Dr.SARAMMA P.P M.N Ph.D 
Senior lecturer in nursing 
Sree chithra  Tirunal institute for medical sciences and technology 
Trivandrum. 
 
2. Prof.JESSIE SUDARSANAM 
H.O.D  of medical surgical nursing 
Annai JKK Sampoorani Ammal College of Nursing 
Komarapalayam 
 
3. Mrs SHOBANA 
Associate professor 
Department of Medical surgical Nursing 
Annai JKK Sampoorani Ammal College of Nursing 
Komarapalayam 
 
4. Dr.SOMARAJAN MD 
Senior consultant oncologists 
Prethyasa institute of cancer  and research centre 
Cherthala,Alappuzha. 
 
5. Dr MOHANAN MD 
Senior oncologist 
Prethyasa institute of cancer  and research centre 
Cherthala,Alappuzha. 
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APPENDIX – V 
 
INFORMED CONSENT FORM 
 
 
I,____________________ understand that I am being asked to participate in a 
research study conducted by 30093601, M Sc (N) II year from Annai J.K.K Sampoorani Ammal 
College Of Nursing, Komarapalayam on “A study to assess the effectiveness of 
cryotherapy on pain after  the intravenous  administration of chemotherapeutic agents 
among  patients with cancer in  selected hospital, Cherthala, Alappuzha”. The study has 
been explained to me. I have been informed that I can with draw from the study at any time. I 
have fully understood the proceeding and give my consent to conduct the study.  
 
 
 
Signature of the subject:                                                      Date:  
 
 
 
Signature of the subject:                                                      Date:  
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APPENDIX – VIII     
[Part-1] 
CRYOTHERAPY INTERVENTION GUIDE 
 
DEFINITION 
Crtotherapy refers to the nursing interventions through continuous  application of ice 
packs. It uses extreme cold to freeze and destroy the tissue it numbs pain, reduces swelling, 
constricts the blood vessels and block nerve impulses to the affected area. 
 
I. PREPARATORY PHASE 
 
A tray containing ice cubes in a plastic container wrapped with a cotton cloth.one 
mackintosh to place under the injection site. 
One more towel to wipe of the area after the procedure.Pain scale to check the level of 
pain.and recording articles. 
 
II. PREPARATION OF CLIENT AND UNIT 
 
1 Explain the procedure to the patient. 
2 Place the mackintosh under the injection site. 
3 Provide comfortable position to the patient. 
4 Cryotherapy plastic container is placed and carried to  the bed side of the patient. 
 
III. ACTION PHASE 
1 wash hands 
2 Wipe the outside of the ice pack and cover it with a cotton cloth. 
3 cryotherapy applying 3cm away from the injection site. 
4 The ice pack is applied for 5-8 minutes. 
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IV  POST CRYOTHERAPY PHASE; 
 
1 The area must be dried well with a towel. 
2 Client must be made comfortable. 
3 Observe the site for any complications. 
4 Wash hands. 
5 Document the patient’s response. 
6 Record the pain level. 
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ABSTRACT 
 
A quasi experimental study to assess the effectiveness of cryotherapy on pain before 
and after the intravenous administration of chemotherapeutic agents among patients with 
cancer in selected hospital, Alappuza district ,Kerala.It was conducted as a partiall fulfillment of 
the requirement for the award of the degree of Master of science in nursing by 30093601 from 
Annai JKK Sampoorani Ammal college of Nursing, under The Tamilnadu Dr.MGR Medical 
University,Chennai, 2010 – 2011. 
             
The objectives of the study were (1) To assess the effectiveness of cryotherapy on 
pain before and  after the intravenous administration of chemotherapeutic agents among the 
cancer patients in experimental group. (2) To compare the mean difference on pain  among the 
cancer patients between the experimental and control group. (3) To test the association 
between the mean difference on pain and selected factors among the cancer patients in 
experimental group. 
  
 The hypothesis formulated were (H1) There will be a significant difference in pain 
before and after cryotherapy  among patients with cancer in experimental group.  (H2) There 
will be a significant difference in the mean difference  of pain among cancer patients  between 
the  experimental and control group. (H3) There will be a significant association between  mean 
difference  in pain and selected factors among  patients with cancer in experimental group. 
 
 Literature review was done and organized under following headings; (1) Studies 
related to pain after the intravenous administration of chemotherapeutic agent. (2) Studies 
related  to pain assessment. (3) Studies related to cryotherapy in general 
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The  conceptual framework adopted for the present study was based on the gate 
control theory proposed in 1965 by Melack and Wall. The research design used was quasi 
experimental, repeated measure time series with control group design. 
 
The tool developed and used for data was interview schedule.Numerical rating scale 
was used to assess the pain. The content validity  of the tool was established by inter rater 
reliability, computed reliability coefficient r=0.86 was high. The pilot study was conducted  
 
The main study  was conducted in the Prethyasa cancer institute and research centre 
at Green gardens hospital, Cherthala. The information regarding background factors  and 
disease related factors were  collected from 46 samples  by interviewing them and  observing 
health records. Pain was measured using numerical rating scale from both the experimental 
and control group. with an interval of 10 minutes. The intervention cryotherapy was for 
experimental group. The evidence of intervention and pain were marked in a grid. Intervention 
was done at the bedside. The experiment was repeated twice during two consecutive doses. 
 
The findings of the study were; There was a significant difference in pain after 
cryotherapy in 1st and 2nd doses. The mean difference on pain during 1st and 2nd intervention 
among cancer patients in experimental and control group was significant 
  
Crotherapy was an effective intervention in reducing pain after the intravenous 
administration of chemotherapeutic agents among cancer patients. The implication limitation 
and recommendation were adequately spelt. 
 
 
